Krisztián Kállay

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial

Christoph Male, Anthonie W.A. Lensing, Joseph S. Palumbo et al. · The Lancet Haematology · 2019 · 294 citations · Full text

Pulmonary Embolism, Thrombosis, Venous Thrombosis +9

Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes

Sushree Sangita Sahoo, Victor B. Pastor, Charnise Goodings et al. · Nature Medicine · 2021 · 161 citations · Full text

Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM)

Peter Bader, Zyrafete Kuçi, Shahrzad Bakhtiar et al. · Bone Marrow Transplantation · 2018 · 107 citations · Full text

Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT)

Philip Connor, Mayte Sánchez van Kammen, Anthonie W.A. Lensing et al. · Blood Advances · 2020 · 105 citations · Full text

Recurrent Vte, Pharmacotherapy, Standard Anticoagulation +17

Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies

Paul Monagle, Anthonie W.A. Lensing, Kirstin Thelen et al. · The Lancet Haematology · 2019 · 74 citations

Thrombosis, Pulmonary Embolism, Venous Disease +9